OBJECTIVES: To perform intravascular imaging of atherosclerotic human coronary conduits in an animal model under conditions of flow and cardiac motion that approximate those encountered in vivo. BACKGROUND: Given the lack of animal models of vulnerable plaque, a model which would allow imaging of human disease and simulate coronary motion and blood flow could advance the development of emerging technologies to detect vulnerable plaques. METHODS: Human coronary segments from adult cadaver hearts were prepared as xenografts. In anesthetized Yorkshire pigs (45-50 kg) the chest was opened and the exposed aorta and right atrium were cannulated and attached in an end-to-end fashion to the human coronary xenograft, forming an aorto-atrial conduit. The xenograft was fixed to the anterior wall of the heart to simulate motion. Angiography and intravascular ultrasound (IVUS) of each graft were performed. RESULTS: Twelve human coronary grafts (10 from right coronary segments) were prepared and implanted successfully in seven animals. All animals tolerated the procedure. The average graft length was 39 +/- 2.3 mm. Blood flow rates distal to the graft were >100 ml/min in nine grafts. IVUS was performed in all 12 grafts and documented expansion of arterial (6.9%) and luminal (9.3%) dimensions during the cardiac cycle (P < 0.001 for both). There was a wide range of coronary atherosclerotic pathology within the grafts, including intimal thickening, fibrocalcific plaque, and deep lipid pools. CONCLUSION: This human-to-porcine coronary xenograft model allows intravascular imaging of human coronary pathology under conditions of blood flow and motion, and may be used to develop technologies aimed at identifying high-risk plaques.
OBJECTIVES: To perform intravascular imaging of atherosclerotichuman coronary conduits in an animal model under conditions of flow and cardiac motion that approximate those encountered in vivo. BACKGROUND: Given the lack of animal models of vulnerable plaque, a model which would allow imaging of human disease and simulate coronary motion and blood flow could advance the development of emerging technologies to detect vulnerable plaques. METHODS:Human coronary segments from adult cadaver hearts were prepared as xenografts. In anesthetized Yorkshire pigs (45-50 kg) the chest was opened and the exposed aorta and right atrium were cannulated and attached in an end-to-end fashion to the human coronary xenograft, forming an aorto-atrial conduit. The xenograft was fixed to the anterior wall of the heart to simulate motion. Angiography and intravascular ultrasound (IVUS) of each graft were performed. RESULTS: Twelve human coronary grafts (10 from right coronary segments) were prepared and implanted successfully in seven animals. All animals tolerated the procedure. The average graft length was 39 +/- 2.3 mm. Blood flow rates distal to the graft were >100 ml/min in nine grafts. IVUS was performed in all 12 grafts and documented expansion of arterial (6.9%) and luminal (9.3%) dimensions during the cardiac cycle (P < 0.001 for both). There was a wide range of coronary atherosclerotic pathology within the grafts, including intimal thickening, fibrocalcific plaque, and deep lipid pools. CONCLUSION: This human-to-porcine coronary xenograft model allows intravascular imaging of human coronary pathology under conditions of blood flow and motion, and may be used to develop technologies aimed at identifying high-risk plaques.
Authors: W J Rogers; J W Prichard; Y L Hu; P R Olson; D H Benckart; C M Kramer; D A Vido; N Reichek Journal: Arterioscler Thromb Vasc Biol Date: 2000-07 Impact factor: 8.311
Authors: Pedro R Moreno; Robert A Lodder; K Raman Purushothaman; William E Charash; William N O'Connor; James E Muller Journal: Circulation Date: 2002-02-26 Impact factor: 29.690
Authors: Sergio Waxman; Murray A Mittleman; Stuart W Zarich; Philip J Fitzpatrick; Stanley M Lewis; David E Leeman; Samuel J Shubrooks; George S Abela; Richard W Nesto Journal: Am J Cardiol Date: 2003-07-01 Impact factor: 2.778
Authors: Alexandra H Chau; Jason T Motz; Joseph A Gardecki; Sergio Waxman; Brett E Bouma; Guillermo J Tearney Journal: J Biomed Opt Date: 2008 Jul-Aug Impact factor: 3.170